Biomarker-based diabetic nephropathy early detection kit

• Main Authors: KHRYSTYNA PRONYUK, OLENA KULIESH, ZHU KONGLIN, ZHANG JUNRAN, GU DONGFENG, PODOBED IVAN, YANG YI, ZHANG GUANJING, LUCA MUSANTE, LIU YAOFENG, SHI JIANGBO
• Format: Patent
• Language: English
• Published: 15.07.2015
• Subjects: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; PHYSICS; TESTING

The utility model discloses a biomarker-based diabetic nephropathy early detection kit. The biomarker-based diabetic nephropathy early detection kit comprises a detection reagent tube set, wherein the detection reagent tube set comprises two or three of a first detection reagent tube, a second detection reagent tube, a third detection reagent tube and a fourth detection reagent tube; the first detection reagent tube comprises first podocalyxin antibody solution, the second detection reagent tube comprises first IV type collagen antibody solution, the third detection reagent tube comprises first liver-type fatty acid binding protein antibody solution, and the fourth detection reagent tube comprises first neutrophile granulocyte gelatinase related lipocalin antibody solution. The biomarker-based diabetic nephropathy early detection kit uses two or three of podocalyxin, IV type collagen, liver-type fatty acid binding protein and neutrophile granulocyte gelatinase related lipocalin as biomarkers, can provide assistant judgment for renal injury according to the practical detection result, and can provide assistance for distinguishing the early diabetic nephropathy.